Clinical evaluation consultant for EU MDR compliance
Clinical evaluation under EU MDR has become one of the most challenging regulatory requirements for medical device manufacturers. Companies are expected to establish a robust Clinical Evaluation Plan (CEP), continuously maintain compliant medical device technical file documentation, and prepare a scientifically justified Clinical Evaluation Report(CER) that demonstrates device safety, clinical performance, and benefit-risk acceptability in accordance with Article 61 and Annex XIV requirements. In practice, many manufacturers struggle with insufficient clinical evidence, inconsistent literature reviews, gaps in state-of-the-art analysis, and increasing scrutiny from notified bodies during MDR conformity assessment procedures. Under Annex XIV, the Clinical Evaluation Report and supporting clinical evidence are considered essential parts of the technical documentation and must be continuously maintained throughout the product lifecycle.
At Billev Pharma East, we provide strategic and scientific support as a trusted
for EU MDR compliance. Our team helps manufacturers develop compliant Clinical Evaluation Plans, prepare and update Clinical Evaluation Reports, and strengthen their overall clinical evidence strategy throughout the product lifecycle. We combine regulatory affairs, medical consultancy, and scientific expertise to support
companies preparing for CE marking, updating legacy device documentation, addressing notified body findings, and maintaining ongoing MDR compliance requirements.